Objectives
Natrelle is born with the objective to manufacture its own products, commercialise and distribute them amongst its wide network within LATAM, MENA, Africa and CIS.
Natrellepharma represents various leading companies across the globe that specialise in biosimilars, antimalarial and Hepatitis C products.
Natrelle relies on its multidisciplinary sales, marketing and regulatory teams for the most up to date technical knowledge in each of these facets of the pharmaceutical business.
In challenging times, our global network is adept to meet exceptional demands of supply, enabling us to deliver medicines or devices to any country in a timeframe of 48 to 96 hours.
LATAM
Our action plan for 2020 – 2025 is defined by growth in LATAM through our regional partners with special incidence in Cuba and Caricom, Central America and Mercosur with our biological products for oncological areas, Hepatitis C, alcoholism and pediatrics.
MENA
Currently, our pediatric offer in Lebanon is well implemented and our objectives are both to continue supporting the local distribution and to increase the portfolio of CE products.
Africa
Recently, we widened our association network through our distribution channels for Congo Brazzaville.
The products against Hepatitis C are being received with positive feedback, as are the antimalarials. One of our ongoing objectives is to extend this same capacity to DRC.
CIS
Our activity in CIS comes from vast support of our product against alcoholism – Meedzo.
Developed and produced in Italy under the supervision of our partner Lasa Laboratorios who are responsible for the distribution of the product within the region.